Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2019  |  Volume : 32  |  Issue : 3  |  Page : 938-942

Study of serum level of vascular endothelial growth factor in patients with hepatocellular carcinoma

1 Department of Internal Medicine, Faculty of Medicine, Menoufia University, Menoufia, Egypt
2 Department of Clinical Pathology, Faculty of Medicine, Menoufia University, Menoufia, Egypt
3 Department of Internal Medicine, Ministry of Health, El-Mahallah El-Kubra, Gharbia, Egypt

Correspondence Address:
Mohamed A. A. Al Diyar
El-Mahallah El-Kubra, Gharbia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/mmj.mmj_901_17

Rights and Permissions

Objective The aim of this study was to investigate the role of serum vascular endothelial growth factor (VEGF) as a marker for diagnosis and early detection of hepatocellular carcinoma (HCC). Background HCC is one of the most common malignancies. VEGF is a master regulator of angiogenesis in normal and malignant tissues. Participants and methods This was a cross-sectional study that was carried out in the Internal Medicine Department of El Menoufia University Hospital, Menoufia, throughout the period from July 2016 to April 2017. This research included three groups: group 1 included 40 cirrhotic patients with HCC, group 2 included 40 patients with liver cirrhosis without HCC, and group 3 included 10 healthy volunteers as a control group. All patients were clinically analyzed, underwent different biochemical assessments and assessment of VEGF. Results Plotting of receiver operating curve implied that serum VEGF, at a cut-off of 872.5 pg/ml showed a diagnostic sensitivity of 83.3% and specificity of 81.7%. The area under the curve (AUC) was 0.8402. As regards serum α-fetoprotein, the diagnostic performance at the cut-off (320 ng/ml) showed a diagnostic sensitivity of 79.41%, specificity of 60%, and AUC of 0.766. As regards combination of serum α-fetoprotein and VEGF, it showed a diagnostic sensitivity of 82.5%, specificity of 80%, and AUC of 0.8842. Conclusion VEGF is suggested to be a promising diagnostic marker with high sensitivity for HCC, which can be used in screening patients with cirrhosis for early detection of HCC.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded28    
    Comments [Add]    

Recommend this journal